Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Diazepam products are in shortage in Canada (4 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A benzodiazepine used to treat anxiety, muscle spasms and certain seizure conditions.
Products affected
4 / 18
In shortage since
Feb 27, 2012
Reports on file
43
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DIAZEPAM INJECTION USP
5MG · SOLUTION · TELIGENT OU
DIN 02385392 · since May 20, 2020, no end estimate · Disruption of the manufacture of the drug.
Active shortage
BIO-DIAZEPAM
BIOMED PHARMA
DIN 02247176 · since Feb 27, 2012, no end estimate · DORMANT
Active shortage
BIO-DIAZEPAM
BIOMED PHARMA
DIN 02247174 · since Feb 28, 2012, no end estimate · DORMANT
Active shortage
BIO-DIAZEPAM
BIOMED PHARMA
DIN 02247173 · since Feb 28, 2012, no end estimate · DORMANT
Resolved
DIASTAT
10MG · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02519070 · ended Dec 15, 2025 · other
Resolved
DIASTAT
15MG · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02519089 · ended May 13, 2025 · other
Resolved
DIASTAT
5MG · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02238162 · ended May 13, 2025 · dating
Resolved
DIASTAT
10MG · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02519070 · ended Mar 10, 2025 · dating
Resolved
VALIUM
5MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 00013285 · ended Oct 9, 2024 · Shortage of an inactive ingredient or component.
Resolved
DIASTAT
5MG · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02238162 · ended Oct 7, 2024 · Capacity Problem in Production
Resolved
DIAZEPAM
5MG · TABLET · AA PHARMA INC
DIN 00362158 · ended Jan 24, 2024 · Disruption of the manufacture of the drug.
Resolved
DIASTAT
15MG · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02519089 · ended Jan 17, 2024 · Demand increase for the drug.
Showing 12 of 43 reports. All reports are on file with Health Canada.
What's happening
Diazepam is currently affected by 4 active shortage reports filed with Health Canada by TELIGENT OU, BIOMED PHARMA.
The reported causes are: disruption of the manufacture of the drug; dormant. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Diazepam is classified under “ANXIOLYTICS” (ATC N05BA).
Recent changes
No changes recorded yet.
Common questions
What is Diazepam used for?
A benzodiazepine used to treat anxiety, muscle spasms and certain seizure conditions.
When will Diazepam be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Diazepam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (anxiolytics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.